Hills Bank & Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$817K Sell
29,104
-12,926
-31% -$344K 0.04% 171
2025
Q4
$1.05M Sell
42,030
-27,290
-39% -$688K 0.06% 153
2025
Q3
$1.77M Sell
69,320
-259
-0.4% -$6.39K 0.1% 110
2025
Q2
$1.69M Sell
69,579
-1,193
-2% -$27.8K 0.11% 112
2025
Q1
$1.79M Sell
70,772
-442
-0.6% -$11.6K 0.13% 107
2024
Q4
$1.89M Buy
71,214
+1,339
+2% +$36.3K 0.14% 96
2024
Q3
$2.02M Sell
69,875
-747
-1% -$21.8K 0.15% 94
2024
Q2
$1.98M Buy
70,622
+531
+0.8% +$14.6K 0.16% 92
2024
Q1
$1.95M Sell
70,091
-136
-0.2% -$3.77K 0.16% 92
2023
Q4
$2.02M Sell
70,227
-575
-0.8% -$17.4K 0.2% 81
2023
Q3
$2.35M Sell
70,802
-7
-0% -$248 0.27% 67
2023
Q2
$2.6M Buy
70,809
+1,419
+2% +$55.2K 0.33% 58
2023
Q1
$2.83M Buy
69,390
+463
+0.7% +$20K 0.39% 51
2022
Q4
$3.53M Buy
68,927
+37
+0.1% +$1.77K 0.52% 39
2022
Q3
$3.01M Sell
68,890
-775
-1% -$37.7K 0.44% 42
2022
Q2
$3.65M Sell
69,665
-455
-0.6% -$23.2K 0.59% 38
2022
Q1
$3.63M Buy
70,120
+1,098
+2% +$57K 0.52% 40
2021
Q4
$4.08M Sell
69,022
-1,920
-3% -$95.1K 0.56% 38
2021
Q3
$3.05M Sell
70,942
-715
-1% -$31.7K 0.46% 44
2021
Q2
$2.81M Buy
71,657
+105
+0.1% +$4.08K 0.43% 52
2021
Q1
$2.59M Sell
71,552
-554
-0.8% -$19.7K 0.42% 52
2020
Q4
$2.65M Sell
72,106
-3,565
-5% -$131K 0.46% 49
2020
Q3
$2.63M Buy
75,671
+10,609
+16% +$372K 0.52% 41
2020
Q2
$2.02M Buy
65,062
+1,667
+3% +$56.6K 0.43% 60
2020
Q1
$1.96M Buy
63,395
+5,458
+9% +$186K 0.58% 40
2019
Q4
$2.15M Buy
57,937
+261
+0.5% +$9.3K 0.51% 45
2019
Q3
$1.97M Buy
57,676
+6,396
+12% +$233K 0.5% 45
2019
Q2
$2.11M Buy
51,280
+2,593
+5% +$103K 0.55% 42
2019
Q1
$1.96M Sell
48,687
-200
-0.4% -$8.01K 0.53% 45
2018
Q4
$2.02M Sell
48,887
-587
-1% -$24.4K 0.63% 38
2018
Q3
$2.07M Sell
49,474
-379
-0.8% -$14.6K 0.56% 43
2018
Q2
$1.72M Sell
49,853
-95
-0.2% -$3.25K 0.49% 46
2018
Q1
$1.68M Sell
49,948
-827
-2% -$28.4K 0.51% 47
2017
Q4
$1.75M Buy
50,775
+28,817
+131% +$983K 0.51% 46
2017
Q3
$743K Sell
21,958
-1,755
-7% -$56.4K 0.23% 82
2017
Q2
$756K Sell
23,713
-666
-3% -$21K 0.24% 80
2017
Q1
$792K Sell
24,379
-169
-0.7% -$5.33K 0.27% 72
2016
Q4
$757K Buy
24,548
+1,956
+9% +$59.7K 0.27% 74
2016
Q3
$726K Buy
22,592
+1,127
+5% +$37.7K 0.26% 77
2016
Q2
$717K Buy
21,465
+928
+5% +$29.6K 0.26% 78
2016
Q1
$578K Buy
20,537
+9,612
+88% +$275K 0.21% 86
2015
Q4
$335K Sell
10,925
-477
-4% -$15K 0.13% 88
2015
Q3
$340K Sell
11,402
-780
-6% -$25K 0.13% 70
2015
Q2
$388K Sell
12,182
-650
-5% -$21.2K 0.14% 64
2015
Q1
$424K Sell
12,832
-3,655
-22% -$116K 0.16% 64
2014
Q4
$488K Sell
16,487
-42
-0.3% -$1.2K 0.19% 62
2014
Q3
$463K Buy
16,529
+6,869
+71% +$193K 0.19% 64
2014
Q2
$272K Sell
9,660
-263
-3% -$7.5K 0.11% 72
2014
Q1
$302K Sell
9,923
-311
-3% -$9.27K 0.13% 67
2013
Q4
$297K Sell
10,234
-158
-2% -$4.6K 0.13% 70
2013
Q3
$284K Sell
10,392
-3,171
-23% -$86.3K 0.14% 69
2013
Q2
$360K Buy
+13,563
New +$375K 0.19% 63

Other funds holding PFE

Hills Bank & Trust's PFE Position: Q1 2026 in Review

Hills Bank & Trust reduced its Pfizer (PFE) stake by 31% in Q1 2026, selling an estimated $344K and leaving 29,104 shares worth $817K. The position accounts for 0.04% of the portfolio, ranked #171.

Hills Bank & Trust first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.08M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Hills Bank & Trust held 29,104 shares of Pfizer worth $817K as of Q1 2026.
  • Hills Bank & Trust sold 12,926 Pfizer shares in Q1 2026, an estimated $344K.
  • Pfizer made up 0.04% of Hills Bank & Trust's portfolio in Q1 2026, its #171 holding.
  • Hills Bank & Trust first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Hills Bank & Trust's Pfizer position peaked at $4.08M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Hills Bank & Trust's 13F filing for Q1 2026, filed 1 May 2026.